Egyszerű nézet

dc.contributor.author Miklya, Ildikó
dc.contributor.author Goltl P
dc.contributor.author Hafenscher F
dc.contributor.author Pencz N
dc.date.accessioned 2019-01-09T12:18:02Z
dc.date.available 2019-01-09T12:18:02Z
dc.date.issued 2014
dc.identifier.citation pagination=67-76; journalVolume=16; journalIssueNumber=2; journalTitle=NEUROPSYCHOPHARMACOLOGIA HUNGARICA;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/6531
dc.description.abstract Parkin (Parkinson juvenile disease protein 2) is a ~52 kDa (426 amino acid) enzyme protein, encoded by PARK2 gene and located on the 6q chromosome. It plays an important role in the ubiquitin-proteasome system and acts as a regulator of protein breakdown. Parkin is located in the cytoplasma until a sustained depolarization occurs as a result of which it is translocated to the mitochondrial surface and induces the degradation of various membrane proteins which are candidates for mitophagia. Parkin is essential for cellular mitochondrial integrity. Parkin mutation leads to the accumulation of missfolded, aggregated proteins and degenerated mitochondria. The role of these changes in the pathomechanism of neurodegenerative diseases is well-known. It was a general belief for a long time that Parkinson's disease is without genetic component a sporadic disease. In 1997 a point mutation was, however, discovered in the alpha-synuclein gene, which caused dominantly inherited parkinsonism. At least 10 other genes were thereafter detected the mutation or deletion of which cause monogenic parkinsonism. Parkin mutation is responsible for about 50% of familial cases and for 10 to 20% of youth cases. According to the present views the improper regulation of protein aggregation and a dysfunction of the ubiquitin-proteasome system may be the common pathway of sporadic and hereditary Parkinson's disease. In the future it might have therapeutic value that parkin has versatile neuroprotective activity (against alpha-synuclein toxicity, proteasomal dysfunction, oxidative stress, kainite-induced and dopamine-mediated toxicity) as a result of which any reduction of parkin level or activity may cause damage in neuronal integrity.
dc.relation.ispartof urn:issn:1419-8711
dc.title A parkin szerepe a Parkinson-kórban
dc.type Journal Article
dc.date.updated 2018-09-27T12:21:18Z
dc.language.rfc3066 hu
dc.identifier.mtmt 2725438
dc.identifier.pubmed 24978049
dc.contributor.department SE/AOK/I/Farmakológiai és Farmakoterápiás Intézet
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet